Introduction
It is known that more than 100 specific enzymes require Zn for their catalytic function emphasising the critical role played by Zn in cellular processes including genomic stability events [1] . Previous evidence has shown genomic instability events as being associated with increased cancer risk [2, 3] . The fact that Zn is required as a cofactor in DNA metabolism, is suggestive that deficiency in this micronutrient may induce important chromosomal mutations that increase cancer risk. Several studies show that Zn deficiency causes DNA oxidation, DNA breaks and chromosome damage [4] [5] [6] .
Mild Zn deficiency has been reported in apparently normal ageing, older individuals with gastrointestinal problems, individuals with compromised immune function and in vegetarians [7] . Ageing populations are at risk of Zn deficiency because of numerous factors such as those reported by the International Zn Nutrition Consultative Steering Committee (2004) [8] .
Zn deficiency has been shown to be prevalent in a number of studies investigating Zn status in elderly populations [9] [10] [11] . Deficiency of Zn may cause impaired immune function [12] [13] [14] , delayed wound healing [15] , depression [16] , impaired cognitive function [17] and increased oxidative stress [18, 19] . As Zn deficiency may have serious implications for the health of ageing individuals, it is important to maintain adequate Zn nutriture within this population.
In 2004, the ZnAge project investigated various health-related impacts of Zn supplementation among the elderly in European countries [16, 18, [20] [21] [22] [23] [24] . Putics et al (2008) concluded that proper dietary Zn may have an important role in anti-aging mechanisms involving the immune system [24] . A further report showed that Zn supplementation reduces spontaneous inflammatory cytokine release and restores T cell function [25] . Marcellini et al (2008) showed that Zn supplementation given to the elderly in the ZnAge project affected Molecular Nutrition & Food Research This article is protected by copyright. All rights reserved.
psychological dimensions dependent on IL-6-174G/C polymorphism [20] . Despite these findings knowledge gaps remain regarding the effect of Zn supplementation in relation to genomic stability and integrity in an elderly population.
The aim of this study was to investigate whether taking a daily supplement of 20 mg of Zn can improve Zn status, genome stability events and Zn transporter gene expression in an elderly (65-85y) South Australian cohort characterised by having low plasma Zn levels (<0.77 mg/L;11.7 µM).
Materials and methods

Screening and recruitment of volunteers
Volunteers were recruited through the CSIRO Clinical Research Unit database and by advertising in local newspapers. The volunteers did not receive any remuneration for their participation. In this study individuals were excluded if 1) supplementing with more than 25% of the recommended dietary intake of Zn, 2) had a habitual dietary Zn intake > 20 mg/day, 3) were undergoing radiotherapy/chemotherapy treatment for cancer and d) had plasma Zn levels > 0.77 mg/L. A total of 208 volunteers aged 65-85 years old met the selection criteria and were screened for plasma Zn status using a non-fasted blood sample collected in the morning in a lithium heparin tube. Those with plasma Zn concentration ≤ 10.0 µM (≤ 0.65 mg/L -cut-off point for Zn deficiency [26] ) were given priority for inclusion in the study. As there were too few individuals with plasma Zn ≤ 0.65 mg/L (10.0 µM), we eventually selected all those with plasma Zn status < 0.77 mg/L (11.77 µM) (n=90) and the volunteers were consented to participate in the study. Body Mass Index was measured and estimated dietary Zn intake using Food Frequency Questionnaire was collected during their
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Intervention design
The study was designed as a randomised, placebo-controlled intervention in a free-living elderly, healthy population. This study was approved by the Human Research Ethics Committee of the CSIRO Food and Nutrition (09/25), University of Adelaide Ethics Committee and Australian New Zealand Clinical Trial Registry (ACTRN: ACTRN12610000059066). Volunteers with low plasma Zn (< 0.77 mg/L;11.7 µM) were randomised into two groups; placebo and Zn supplemented group.
The Zn supplement tablet used in this trial is a commercially available Zn carnosine chelate supplement, which was supplied and prepared by Metagenics (Queensland, Australia). Each Zn carnosine supplement tablet contained 86.9 mg of Zn carnosine with maltodextrin as excipient. The placebo tablet was 100% pure maltodextrin. The Zn dose in each supplement tablet was 20 mg/day which is within the safe physiological range [8] . The placebo group received an identical tablet, which only contained the excipient maltodextrin.
The volunteers consumed one tablet (Placebo or Zn carnosine) per day.
Nutritional assessment
A nutrition survey was carried out to investigate the estimated dietary intake of Zn in the study cohort. The volunteers who participated in the study were required to complete the validated Anti-Cancer Council of Victoria (ACCV) Food Frequency Questionnaire at the start of the study [27] and analysed with NUTTAB95 nutrient composition data [27] .
Blood collection and sample preparation
For screening, one tube (5 ml) of non-fasted blood per volunteer was collected in a lithiumheparin vacutainer (Vacuette, Austria). During the intervention, at baseline and 12 weeks, three tubes of blood (6-8 ml for each) were collected in the morning after an overnight fast into a potassium-EDTA tube for homocysteine (Hcy) measurement, and another two lithiumheparin tubes for all other assays. Molecular Nutrition & Food Research This article is protected by copyright. All rights reserved.
a) Plasma Isolation
Blood was spun at 3000 rpm for 20 minutes at 4°C and plasma was transferred into new tubes according to the assays to be investigated. Spare plasma was labelled and kept at -80°C.
b) Isolation and storage of lymphocytes
Lymphocytes were isolated using Ficoll-Paque™ (Amersham Pharmacia Biotech). For the Cytokinesis block micronucleus cytome (CBMN Cyt) assay, a total cell count was performed and 750 µl cultures were set up at 1x10 6 /ml, in duplicate. Cultures were placed in an incubator at 37°C with 5% CO 2 until ready for phytohaemagglutinin (PHA) addition. For the alkaline comet assay, 500 µl of 1X10 5 cells/ml suspension was prepared for each volunteer. Spare cells were spun down and resuspended in 500 µl PBS with 10% DMSO (Sigma, Australia), then stored in -80°C prior to DNA/RNA isolation. The remaining blood was collected and transferred into new tubes and kept at -20 °C prior to erythrocyte superoxide dismutase measurements. 
Plasma analysis
b) Ferric Reducing Ability of Plasma (FRAP) analysis
The FRAP assay was used to measure the combined antioxidant effect of the non-enzymatic defences in plasma samples [28] . The absorbance of the products of the FRAP reaction was measured on an ELISA microplate reader (SpectraMax 250, Molecular Devices, CA, USA) at a wavelength of 593 nm. 96 well plates were used in this assay for multiple readings as only 300 µl solution was used for absorption readings.
c) eSOD assay
For this analysis, we used the SOD assay kit (Trevigen Inc, USA). A standard curve to verify that the assay is working predictably and that concentration dose-response is linear within the relevant range was established prior to analysis of samples
DNA Damage assays a) CBMN-Cyt assay
Following Cyto-B treatment, cells are harvested following a well validated protocol onto slides by cytocentrifugation, stained and scored for chromosomal damage biomarkers using light microscopy [29] . 500 cells were scored to determine the frequency of necrotic, apoptotic, mono-, bi-and multi-nucleated cells and nuclear division index (NDI). 1000 binucleated cells were scored to determine the frequency of chromosomal DNA damage biomarkers including micronuclei (MNi), nucleoplasmic bridges (NPB) and nuclear buds (NBUDs).
b) Alkaline comet assay
Single cell gel electrophoresis (comet assay) was used to measure DNA strand breaks and alkaline labile sites in lymphocytes. The assay was conducted under alkaline conditions as previously described [30, 31] This article is protected by copyright. All rights reserved.
Isolation of DNA/RNA
DNA and RNA were isolated from lymphocytes using TRIzol (Ambion). A 0.5 ml volume of trizol was used to homogenise each sample. The only alteration from the manufacturer's directions was the use of 2 µg/ml glycogen (Ambion) and 5 mM sodium acetate to aid RNA precipitation.
a) Telomere length
A quantitative real-time polymerase chain reaction (qPCR) based method was used to measure absolute telomere length (aTL). This method is based on the Cawthon method for relative measurement of telomere length (TL) but modified by introducing an oligomer standard to measure aTL and was performed as previously described [32] [33] [34] .
b) Telomere base damage
Telomere base damage was measured using a qPCR based method [35] to measure the amount of oxidised residues as well as other base lesions within telomeric DNA that are recognised and excised by the bacterial enzyme, formamidopyrimidine DNA-glycosylase (FPG). This method is based on differences in PCR kinetics between the DNA template exhaustively digested by FPG and undigested DNA i.e. ∆C T (C T treated-C T untreated) and was performed as previously decribed [35] . 
Statistical analysis
With 40 subjects per group, the study had 80% power to detect an increase in plasma Zn of This article is protected by copyright. All rights reserved. Table 1 ). However, plasma Zn values at screening were marginally but significantly lower in the placebo group (0.69 ± 0.06 mg/L) compared to the Zn group (0.71 ± 0.04 mg/L). Compliance rate was high (>98%) with respect to tablet consumption in both groups.
Results
Characteristics of the volunteers
Plasma micronutrients: Zinc, Carnosine, Mineral, B12, Folate and Homocysteine
At baseline, no difference between groups was observed, but significant change was found at the end of 12 weeks intervention. In the placebo group, plasma Zn showed a significant drop (Table 2) .
Antioxidant activity (FRAP and eSOD)
Antioxidant activity measured via FRAP was significantly increased in the Zn group following 12 weeks of supplementation (p<0.05) from 1180.62 ± 315.40 to 1447.79 ± 471.58 µmol/L (Table 2) . However, no significant difference between groups was observed following the intervention. eSOD which reflects Cu-Zn SOD activity in erythrocytes was also significantly increased in the Zn group following the 12 week intervention and the changes were significant between groups (p<0.05). eSOD showed a 33.07% increment (relative to baseline) in the Zn group, compared to the Placebo group which showed only 2.45%
increment (relative to baseline) (Figure 2). Molecular Nutrition & Food Research
DNA damage assays: CBMN-Cyt assay and alkaline comet assay
The CBMN-Cyt assay results (Table 3) , showed a significant decrease in the frequency of MNi for the Zn group following supplementation (p<0.05). The reduction of 24.18%
(relative to baseline) was statistically significant compared to the placebo group which showed an increase of 1.77% (Fig 3) . There were no significant changes in the frequency of NPB and NBUD for both groups. Both tended to decrease in the Zn supplemented group but the changes were not significant. Necrotic cells were higher in the placebo group following 12 weeks intervention with a significant increase of 44.28% (relative to baseline). However, no change was observed in the percentage of necrotic cells in the Zn supplemented group with only an 18.21% increase relative to baseline. Apoptotic cells were decreased in the Zn group (p<0.05) following the duration of intervention with a reduction of 7.53% relative to baseline. NDI was increased in both groups following the 12 weeks of intervention (p<0.05) (Table 3 ) but no significant change between groups was observed.
The comet assay results showed a significant effect of time and treatment of Zn supplementation for both tail moment and tail intensity (p<0.05) ( Table 3) . Tail (Fig 4) . Tail moment and tail intensity in the Placebo group showed a significant 141.6% and 28.95% increase respectively relative to baseline (p<0.
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Telomere integrity: Telomere length and telomere base damage
Telomere length was found to be shorter in the Zn supplemented group following the 12 week intervention but the difference was not significant relative to the Placebo group. Both groups showed a significant increase in telomere length within groups following 12 weeks of intervention with an increment of 9.65% for the Zn supplemented group and 10.36% for the Placebo group (relative to baseline) (Fig 5) . showed a 19.09% increase relative to the baseline measure, compared to a 9.38% increase in the Placebo group (Fig 6) .
Correlation between plasma Zinc and other measured biomarkers
Pearson correlation analysis of the relationship between plasma Zn (at the baseline and at the end of the study) with other biomarkers was performed (Supporting Information Partial correlation analysis of the relationships between plasma Zn (at the start and at the end of the trial), after controlling for age and gender, and all biomarkers in this study was also performed. At baseline, no correlation between plasma Zn and other plasma and DNA damage biomarkers was observed. At the end of 12 weeks of supplementation, plasma Zn was found to be correlated only with ZIP1 expression (r=0.576, p=0.039) (Supporting Information Table 3 ).
Correlation between other measured biomarkers
Based on the partial correlation, at baseline, vitamin B12 was correlated with folate (r=0. 
Discussion
The results of this study show that Zn carnosine supplementation in an elderly population is beneficial in reducing the micronucleus frequency measured by the CBMN Cytome assay and both tail moment and intensity as measured via the comet assay following 12 weeks of intervention. To the authors' knowledge, this is the first study conducted to investigate the impact of Zn supplementation on CBMN Cytome biomarkers and telomere integrity in an
Plasma Zn at baseline was found to be higher than plasma Zn levels at screening. This may possibly be due to the fasting state and diurnal variation as both can affect plasma Zn concentrations [8] . Volunteers who were fasting tended to have higher plasma Zn compared to non-fasting volunteers [8] . This possibly explains why in our study, a lower plasma Zn was observed at screening but the value increased at baseline although they were from the same cohort. According to Brown (1998) [38] , in a population aged 22-75 years old, the reference value for plasma Zn is 16.6 ± 6.2 µM. The lower limit of fasting plasma Zn levels has been recommended at 10.7 µM [39] and therefore the cut-off level below which a Zn-deficient status is possible [40] . The cut off point for Zn deficiency was set to 11.6 µM in order to obtain 90 people with the lowest Zn status at screening, which was slightly higher than the 10.7 µM value recommended.
An increase of 5.40% in plasma Zn after 12 weeks of supplementation in the Zn group indicates that daily intake of Zn at 20 mg/day improved Zn status. Savarino et al (2001) [41] showed that high plasma Zn in older individuals may contribute to their longevity. The increased plasma Zn levels is in agreement with the beneficial effect of Zn supplementation reported in an older institutionalized population presenting a large prevalence of biological Zn deficiency (< 10.7 µM) [42] .
In this study, we also measure plasma levels of other minerals to see the changes and correlation with plasma Zn and other variables. Calcium and magnesium concentration appeared to increase in both the Placebo and Zn groups. This could be explained by the excipient maltodextrin in the zinc carnosine and placebo tablets. A recent study in rats showed that maltodextrin increased absorption of calcium, magnesium, iron and zinc from the diet possibly by increasing bacterial fermentation in caecum [43] . However, in our study iron and zinc concentration did not increase in plasma which suggests that the effects of maltodextrin on mineral absorption in humans may be limited to calcium and magnesium.
Further studies in humans are required to test this hypothesis. Molecular Nutrition & Food Research
Concentration of plasma B12, folate and Hcy were also measured as these may affect DNA damage and telomere maintenance [44] [45] [46] . It was found that Zn supplementation did not alter plasma B12, folate and Hcy substantially although a trend for increased plasma folate in the Zn group was evident. These results are in agreement with a previous study by Ducros et al 2009 [47] that showed after six months of intervention with Zn at 15 mg/day and 30 mg/day, there was no effect on Hcy, B12 and folate levels. It is evident that the extent of Zn deficiency in our cohort was not sufficient to substantially alter plasma B12 and Hcy levels in plasma and Zn supplementation may have contributed marginally to improved folate concentration in plasma.
The impact of Zn supplementation in relation to the antioxidant profile (FRAP and eSOD) of the participants was also investigated. It was shown that FRAP and eSOD were increased following Zn supplementation. This result is similar to a previous study that reported Zn supplementation increased the eSOD activity following both 3 and 6 month interventions [48] . However, in the same study, an increase in FRAP was not found. This negative result following Zn supplementation may have been because only 4.8% were middle-aged and 5.6% were older subjects that were below the cut off level for biological Zn deficiency (10.7 µM) [48] . In another study, Song et al [49] found that FRAP activity was unaffected following Zn supplementation while eSOD tended to decrease after marginal Zn depletion and increased after Zn repletion, but the changes were not statistically significant.
To our knowledge, this is the first study to investigate the effect of Zn supplementation on genome stability in an elderly South Australian population. A reduction in the micronucleus frequency was observed together with both tail moment and tail intensity as measured via the alkaline comet assay following 12 weeks intervention with Zn at 20 mg/day. A previous study in rats has shown that severe Zn depletion caused an increase in
DNA damage in peripheral blood cells compared to Zn replete controls and this was Molecular Nutrition & Food Research
associated with impairment in DNA repair, compromised p53 DNA binding, and upregulation of the base excision repair (BER) proteins, OGG1 and PARP [50] . A further study conducted in rats showed that marginal Zn deficiency (MZnD) caused an increase in oxidative DNA damage in the prostate after chronic exercise [51] . Dietary Zn restriction and repletion of Zn to its normal status was found to affect DNA integrity in healthy men aged 19-50 years old [49] . Plasma Zn concentrations showed a negative correlation with DNA damage measures as measured via the alkaline comet assay (r=-0.47, p=0.014) in agreement with our study [49] .
Zinc carnosine at optimal concentration in cells was shown to have an impact on Zn status and to have lower DNA damage events as measured via CBMN Cytome assay as well as following induced damage [52] [53] [54] . Activation of MT and SOD was predicted to be key components in this effect as measured via protein expression, in addition to activation of PARP and OGG1 [54] . This is in line with our results that observed an increase in eSOD following Zn supplementation. In addition, Zn is an essential component for PARP-1, which binds via its Zn domain to DNA strand breaks and thereby assisting in the recruitment of DNA repair complexes [55] . Positive correlation between cellular poly(ADP-ribosyl)ation and Zn status in human peripheral blood mononuclear cells was reported previously [56] , indicating that Zn plays an important role in maintaining genomic stability [5] . Besides, Zn is also part of OGG1 which is another DNA repair enzyme that is involved in base excision repair by removing of 8-hydroxyl-2'-deoxyguanosine, one of the more prevalent oxidative DNA damage events [57] .
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These studies suggest that Zn deficiency may lead to an increase in DNA damage and in our study it was shown that Zn supplementation may be beneficial in lowering DNA damage especially DNA strand breaks and the frequency of micronuclei. In this study, Zn carnosine was used and it has been shown that carnosine is a potent antioxidant [58] and may have an impact on DNA damage. The levels of carnosine were very low and did not change significantly in the treatment group versus the placebo. However, plasma carnosine was inversely correlated with micronuclei at week 12 (r=-0.564) but not at baseline, and inversely with comet tail intensity at baseline (r=-0.236) but not at week 12. This suggests that the possibility that significant changes in carnosine concentration in blood may affect genome stability in lymphocytes cannot be disregarded.
The relationship between Zn status and telomere biology is not clearly defined.
Accelerated telomere shortening may result in a DNA damage response leading to chromosomal end-to-end fusions, cell arrest and apoptosis [44, 59, 60] . No difference in telomere length and telomere base damage between the placebo and Zn treatment group was observed in this current study. However, telomere length was observed to increase and telomere base damage decreased in the Zn supplemented group when week 12 data was compared to baseline. This suggests that the effects are small or a larger study is required to achieve statistically significant time and treatment interaction. There are actually very few studies that have investigated the impact of Zn on maintaining telomere integrity. Liu and colleagues (2004) found that Zn sulphate at 80 µM accelerated telomere loss in hepatoma cells (SMMC-7721) after 4 weeks of treatment [61] . Cells with short telomeres are associated with impaired Zn homeostasis in hypertensive patients [62] .
In this study, we focused on the measurement of main Zn transporter for human which are MT1A and ZIP1. Gene expression analysis showed that Zn supplementation over 12 weeks of intervention increased both MT1A and ZIP1 expression significantly. These genes were selected because both are expected to be responsive to Zn concentration because of their important role in Zn transport and Zn storage [1, 63] . MT has been found to affect the release of Zn for the activity of PARP-1, which is involved in base excision DNA-repair [64] .
Previous studies have shown that Zn and metallothionein are genome-protective against the insults associated with oxidative stress [65] [66] [67] . In our study, MT expression was increased in the Zn group which may explain the reductions in both tail moment and tail intensity observed in the comet assay and also the frequency of micronuclei.
In particular, polymorphisms of the metallothionein gene MT1A were found to influence the efficacy of Zn supplementation [21, 23] . This article is protected by copyright. All rights reserved.
Conclusion
The results from this study show that Zn supplementation in an elderly populations with low Zn status can (a) improve Zn status, (b) lower DNA damage events, hence improving genome stability, (c) increase antioxidant activity which may lower DNA damage risk [6] , and (d) increase Zn storage and transporter gene expression (MT1A and ZIP1). Given that there is some evidence that the benefits and/or adverse effects of Zn supplementation may depend on genotype variations e.g. (MT1A) [18, 20, 23] , it will be necessary to find out in future whether there are specific genotypes or polymorphisms in genes in high susceptibility groups, who are more likely to benefit, or be at risk of any toxic effect of Zn supplementation.
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